Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases

Stopped Study was never opened to accrual. There is no clinical benefit to patients.

Conditions

• Recurrent Melanoma
• Stage IV Melanoma
• Tumors Metastatic to Brain

Interventions

• DRUG: Vemurafenib
• RADIATION: Whole-brain radiation therapy (WBRT)
• RADIATION: Radiosurgery (SRS)

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborators

• [object Object]